Chemed (CHE) Asset Writedowns and Impairment (2009 - 2020)

Chemed (CHE) has reported Asset Writedowns and Impairment for 10 consecutive years, with -$443000.0 the latest figure, recorded in Q4 2020.

• In Q4 2020, Asset Writedowns and Impairment changed N/A year-over-year to -$443000.0; the TTM figure through Dec 2020 stood at $601000.0 (changed N/A YoY), while the FY2020 annual figure was $657000.0, changed N/A from the prior year.
• Asset Writedowns and Impairment came in at -$443000.0 for Q4 2020 at Chemed, down from $185000.0 in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $4.7 million in Q3 2017, with the low at -$443000.0 in Q4 2020.
• Average Asset Writedowns and Impairment over 3 years is $2.9 million, with a median of $4.0 million recorded in 2016.
• The largest YoY upside for Asset Writedowns and Impairment was 33.05% in 2016 against a maximum downside of 1.22% in 2016.
• Year by year, Asset Writedowns and Impairment stood at $4.2 million in 2016, then rose by 3.96% to $4.4 million in 2017, then slumped by 110.18% to -$443000.0 in 2020.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered -$443000.0, $185000.0, and $265000.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.